Work

Supplementary Figures S1-S5, Tables S1-S5 from Cytotoxicity of Human Endogenous Retrovirus K–Specific T Cells toward Autologous Ovarian Cancer Cells

Year: 2023

Type: supplementary-materials

Abstract: Figure S1. Schematic for patient sample preparation and IVS procedure; S2. Schematic representation of HERV transcripts; S3. Ovarian (cancer) patient characteristics; S4. OC cells in the ascites express cancer stem cell markers and both epithelial and mesenchymal cell markers; S5. Characterizations of OC cells and expression HERV-K transcripts and protein; Supplementary Table S1. Clinicopathologic characteristics and use of patient samples; S2. Normal Samples* S3. Marker analysis in primary cells from normal, benign, and malignant ovarian tissues; S4. Primers used in semi-quantitative RT-PCR analysis of various HERV-K transcripts; S5: Characterization of patient PBMCs and IVS cells.

DOI: 10.1158/1078-0432.22460861

Authors: Kiera Rycaj, Joshua B. Plummer, Bingnan Yin, Ming Li, Jeremy Garza, Laszlo Radvanyi, Lois M. Ramondetta, Kevin Lin, Gary L. Johanning, Dean G. Tang, Feng Wang-Johanning

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362399396

Cites:

Cited by:

Related to: 10